Astellas Pharma and Vical asserts negative Phase 3 Clinical Trial results for ASP0113 for CMV-HSCT recipients Read more
Agenus launches its Clinical Trial combination of its anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies Read more
AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer Read more
OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients Read more
Eiger Biopharmaceuticals disappointed over negative results of Phase 2 LIBERTY study in PAH Read more
Marina Biotech enters into agreement with Autotelic Bio for developing Marina’s IT-103 Clinical program Read more